Research into areas like cancer could become collateral damage of a broader anti-mRNA push, according to a new study.

The COVID pandemic ushered mRNA vaccines into the spotlight, and the technology has even greater potential. Here’s what to ...

The FDA is reviewing the first mRNA flu vaccine for adults 50 and older. Learn how this technology could lead to faster and ...

Moderna's full pipeline may fuel long-term growth.

BioNTech envisioned the site making hundreds of millions of vaccines a year, but has since shifted its pipeline to other ...

Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr. canceled $500 million of funding for research on mRNA vaccine technology ...

Learn how pharma company Pfizer makes money through prescription drugs, vaccines, oncology treatments, and global ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of uncertainty, scientists worry that revolutionary treatments for cancer, immune ...

EDITOR’S NOTE: The views expressed in this commentary are solely those of the writer. CNN is showcasing the work of The Conversation, a collaboration between journalists and academics to provide news ...